: In adults with SMA, risdiplam therapy may improve respiratory function. In these patients, sniff nasal inspiratory pressure is the most effective test to demonstrate effects of pharmacological therapy. https://bit.ly/3Wk2MCU.
Crescimanno, G., Alonge, P., Lupica, A., Tomasello, V., Di Stefano, V., Brighina, F., et al. (2026). Evaluating effects of risdiplam in adults with spinal muscular atrophy: a monocentric study. ERJ OPEN RESEARCH, 12(2), 1-4 [10.1183/23120541.01120-2025].
Evaluating effects of risdiplam in adults with spinal muscular atrophy: a monocentric study
Alonge, Paolo;Lupica, Antonino;Di Stefano, Vincenzo;Brighina, Filippo;
2026-03-01
Abstract
: In adults with SMA, risdiplam therapy may improve respiratory function. In these patients, sniff nasal inspiratory pressure is the most effective test to demonstrate effects of pharmacological therapy. https://bit.ly/3Wk2MCU.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Evaluating effects of risdiplam in adults with spinal muscular atrophy- a monocentric study.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
364.56 kB
Formato
Adobe PDF
|
364.56 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
